Zhu Jinrong, Zhao Yana, Huang Wei, Zhao Weiwei, Wang Yue, Wang Song, Su Chunyan
Department of Nephrology, Peking University Third Hospital, Beijing 100191, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Apr 18;56(2):267-272. doi: 10.19723/j.issn.1671-167X.2024.02.010.
To analyze the clinical characteristics of hemodialysis patients with corona virus disease 2019 (COVID-19) in a single-center from Beijing.
Patients with COVID-19 who received regular hemodialysis at Peking University Third Hospital from November 30, 2022 to January 4, 2023 were selected as the study objects. Clinical symptoms, severity and duration of symptoms during the period of virus positive were investigated in the form of questionnaires, and the basic information of the patients, as well as the results of blood tests (routine blood and blood biochemistry, .) before and after infection, dialysis treatment and the outcome of the disease were collected by consulting medical records.
A total of 203 subjects were included in this study, including 148 mild cases (72.91%), 23 medium cases (11.33%), 32 severe and critical cases (15.76%), and 16 (7.88%) deaths occured during the follow-up. Clinical symptoms mainly included respiratory symptoms (among which 81.77% had cough, 68.97% had expectoration), fever (81.28%) and fatigue (65.52%), and fatigue and weakness had the longest duration [9 (5, 15) days] among all symptoms. Twenty-six patients (12.8%) reduced the dialysis sessions [1 (1, 2) times], 25 patients (12.32%) had the behavior of early finishing dialysis (27 times), reducing the dialysis time by 30.0 (20.0, 30.5) minutes. Univa-riate analysis showed that the hemoglobin, creatinine, urea nitrogen and ultrafiltration decreased signi-ficantly after infection ( < 0.05). There were significant differences in age, albumin, hemoglobin, creatinine levels and vascular access types among the patients with different clinical subtypes, and the changes of dialysis sessions, fever, expectoration and fatigue degree were also different among the patients with different clinical subtypes ( < 0.05). Multivariate Logistic regression analysis showed that age (=1.051, 95%: 1.017-1.086, =0.003) and albumin levels (=0.905, 95%: 0.803-1.019, =0.098) corrected by fever, expectoration and fatigue levels were still associated with the occurrence of pneumonia.
The morbidity of pneumonia and the proportion of deaths in hemodialysis patients with COVID-19 were higher, and some clinical symptoms lasted for a longer time than the general population. During the infection period, the incidence of dialysis-related complications increased, hemoglobin and nutritional status decreased. Elderly patients and patients with low albumin level had a higher risk of developing pneumonia after infection.
分析来自北京某单中心的2019冠状病毒病(COVID-19)血液透析患者的临床特征。
选取2022年11月30日至2023年1月4日在北京大 学第三医院接受规律血液透析的COVID-19患者作为研究对象。以问卷形式调查病毒阳性期间的临床症状、严重程度及症状持续时间,通过查阅病历收集患者的基本信息以及感染前后的血液检查结果(血常规、血生化等)、透析治疗情况及疾病转归。
本研究共纳入203例受试者,其中轻症148例(72.91%),中症23例(11.33%),重症及危重症32例(15.76%),随访期间死亡16例(7.88%)。临床症状主要包括呼吸道症状(其中咳嗽占81.77%,咳痰占68.97%)、发热(81.28%)及乏力(65.52%),乏力和虚弱在所有症状中持续时间最长[9(5,15)天]。26例患者(12.8%)减少了透析次数[1(1,2)次],25例患者(12.32%)有提前结束透析行为(27次),透析时间减少30.0(20.0,30.5)分钟。单因素分析显示,感染后血红蛋白、肌酐、尿素氮及超滤量显著下降(P<0.05)。不同临床分型患者的年龄、白蛋白、血红蛋白、肌酐水平及血管通路类型存在显著差异,不同临床分型患者在透析次数、发热、咳痰及乏力程度的变化方面也存在差异(P<0.05)。多因素Logistic回归分析显示,校正发热、咳痰及乏力水平后的年龄(β=1.051,95%CI:l.017-1.086,P=0.003)及白蛋白水平(β=0.905,95%CI:0.803-1.019,P=0.098)仍与肺炎的发生相关。
COVID-19血液透析患者肺炎发病率及死亡比例较高,部分临床症状持续时间较普通人群长。感染期间,透析相关并发症发生率增加且血红蛋白及营养状况下降。老年患者及白蛋白水平低的患者感染后发生肺炎的风险较高。